16 Feb 2017
Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China
This week, Phispers highlights more bad news for Israeli drugmaker Teva, along with news on the ‘overwhelming efficacy’ of blood thinner Rivaroxaban over Aspirin, Sanofi’s plans to resubmit its application for Sa...
15 Feb 2017
Will a Spanish drug, retailing for under 10 euros, get sold in the U.S. for $89,000/year?
On February 9, 2017 Marathon Pharmaceuticals LLC received FDA approval for Emflaza (deflazacort), tablets and oral suspension, to treat patients aged 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorde...
09 Feb 2017
FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More
After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research approved 22 novel drugs in 2016, down from the 19-year high of 45 in 2015. The FDA also approved...